Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy

Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy

US Patent 11565005 · Granted Jan 31, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inflammasome-targeted RNA interference approach to treating kidney injury and di2025
Anti-polysialic acid antibodies and uses thereof2025
Multimodal silica-based nanoparticles2024
Crystalline forms of an androgen receptor modulator2024
Multi-specific antibodies with affinity for human A33 antigen and DOTA metal com2024
Multi-specific antibodies with affinity for human A33 antigen and DOTA metal com2024
Anti-CD20 antibody and uses thereof2023
One-step labeling of antibodies to high specific activity with actinium-2252023
Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabel2023
Uses of labeled HSP90 inhibitors2023
Single wall nanotube constructs and uses thereof2023
Multimodal silica-based nanoparticles2022